MedPath
HSA Approval

APO-FLUVOXAMINE 100MG TABLET

SIN13559P

APO-FLUVOXAMINE 100MG TABLET

APO-FLUVOXAMINE 100MG TABLET

October 7, 2008

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N06AB08

fluvoxamine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

FLUVOXAMINE MALEATE

100 mg

Fluvoxamine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-FLUVOXAMINE 100MG TABLET - HSA Approval | MedPath